A summer COVID-19 surge has led to a likely rise in infections in half of U.S. states, according to the Centers for Disease Control and Prevention, a spike that comes as drug makers await approval for new vaccines that will target the coronavirus’ latest variant—though hospitalizations remain fairly low.
